Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
Open Access
- 1 October 2020
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (10) , 1383-1386
Abstract
No abstract availableKeywords
Funding Information
- CHILDREN with CANCER UK
- Cancer Prevention Research Trust
- The Humane Research Trust
- The Myositis Association
- The Caring Cancer Trust
- Medical Research Council (MR/N003322/1)
This publication has 7 references indexed in Scilit:
- Myositis as a manifestation of SARS-CoV-2Annals of the Rheumatic Diseases, 2021
- A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2Cell Host & Microbe, 2020
- Microbial and autoantibody immunogenic repertoires in TIF1γ autoantibody positive dermatomyositisbioRxiv, 2020
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronavirusesNature Microbiology, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Identification of distinctive interferon gene signatures in different types of myositisNeurology, 2019
- Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patientsJournal of Autoimmunity, 2019